Retrospective Record-review Study in Patients Who Had Diabetic Foot Ulcer

Oneness Biotech

Status: Unknown

Conditions: Diabetic Foot Ulcer

Treatments: Drug: ON101 Cream

Study type: Observational

Funder types: Industry

Identifiers

NCT05135130

ON101CLOS01

Details and patient eligibility

About

The purpose of the study is to evaluate the medical cost of illness for DFUs on the patients who had used ON101 or Aquacel® in the ON101CLCT02 trial.

Enrollment: 176 estimated patients

Sex: All

Ages: 20 to 79 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

No additional inclusion or exclusion criteria will be applied.

Trial design

176 participants in 2 patient groups

ON101 Cream

Description:

Patients Who Had Participated in the ON101CLCT02 Diabetic Foot Ulcer Trial and assigned to ON101 Cream arm

Treatment:

Drug: ON101 Cream

Aquacel® Hydrofiber® dressing

Description:

Patients Who Had Participated in the ON101CLCT02 Diabetic Foot Ulcer Trial and assigned to Aquacel® Hydrofiber® dressing arm